The Finnish Competition Authority publishes its pharmacy market study and proposes measures to reduce the costs of medicines for consumers and society

The FCCA pharmacy market study proposes measures to reduce the costs of medicines for consumers and society* The Finnish Competition and Consumer Authority (FCCA) has published an extensive study on the pharmacy market. The study produced a list of proposals that can reduce the pharmaceutical costs for consumers and society and improve access to medicines. The profits generated by pharmacies for their owners have repeatedly been found to be relatively high, which is reflected in the pharmaceutical costs of consumers and society. Pharmacies operate in a growing market of approximately EUR 2.5 billion, which is heavily regulated. Pharmaceutical safety sets its own restrictions on how the sale of medicines can be organised. Nevertheless, customers and society could buy their medicines

L'accès à cet article est réservé aux abonnés

Déjà abonné ? Identifiez-vous

L’accès à cet article est réservé aux abonnés.

Lire gratuitement un article

Vous pouvez lire cet article gratuitement en vous inscrivant.

 

Version PDF

Auteur

Citation

Finnish Competition Authority, The Finnish Competition Authority publishes its pharmacy market study and proposes measures to reduce the costs of medicines for consumers and society, 11 novembre 2020, e-Competitions November 2020, Art. N° 98020

Visites 37

Tous les numéros

  • Latest News issue 
  • Tous les News issues
  • Latest Special issue 
  • Tous les Special issues